Quanterix Corp
NASDAQ:QTRX
Intrinsic Value
Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. [ Read More ]
The intrinsic value of one QTRX stock under the Base Case scenario is 25.78 USD. Compared to the current market price of 15.56 USD, Quanterix Corp is Undervalued by 40%.
Valuation Backtest
Quanterix Corp
Run backtest to discover the historical profit from buying and selling QTRX stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Quanterix Corp
Current Assets | 378.4m |
Cash & Short-Term Investments | 321.3m |
Receivables | 25.4m |
Other Current Assets | 31.7m |
Non-Current Assets | 46.6m |
PP&E | 36.2m |
Intangibles | 6m |
Other Non-Current Assets | 4.4m |
Current Liabilities | 38.5m |
Accounts Payable | 5m |
Accrued Liabilities | 23.9m |
Other Current Liabilities | 9.5m |
Non-Current Liabilities | 39.6m |
Other Non-Current Liabilities | 39.6m |
Earnings Waterfall
Quanterix Corp
Revenue
|
122.4m
USD
|
Cost of Revenue
|
-51.7m
USD
|
Gross Profit
|
70.6m
USD
|
Operating Expenses
|
-118.8m
USD
|
Operating Income
|
-48.2m
USD
|
Other Expenses
|
15.8m
USD
|
Net Income
|
-32.3m
USD
|
Free Cash Flow Analysis
Quanterix Corp
QTRX Profitability Score
Profitability Due Diligence
Quanterix Corp's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
Score
Quanterix Corp's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
QTRX Solvency Score
Solvency Due Diligence
Quanterix Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
Quanterix Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
QTRX Price Targets Summary
Quanterix Corp
According to Wall Street analysts, the average 1-year price target for QTRX is 33.66 USD with a low forecast of 31.31 USD and a high forecast of 36.75 USD.
Ownership
QTRX Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
QTRX Price
Quanterix Corp
Average Annual Return | 4.86% |
Standard Deviation of Annual Returns | 65.89% |
Max Drawdown | -92% |
Market Capitalization | 603.3m USD |
Shares Outstanding | 38 063 600 |
Percentage of Shares Shorted | 2.79% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The company is headquartered in Billerica, Massachusetts and currently employs 460 full-time employees. The company went IPO on 2017-12-07. The firm is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to reliably detect protein biomarkers at extremely low concentrations in blood, serum and other fluids. Its products include HD-X Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, and 2470 Arrayer. The company also supplies NF-Light antibodies and ELISA kits, which offer solutions for the detection of neurofilament light (Nf-L) for the development of therapeutics and diagnostics for neurodegenerative conditions. Its portfolio of available kits spans multiple therapeutic areas, including cardiology, infectious disease, inflammation, neurology, and oncology. The company provides services through its Simoa Accelerator Laboratory.
Contact
IPO
Employees
Officers
The intrinsic value of one QTRX stock under the Base Case scenario is 25.78 USD.
Compared to the current market price of 15.56 USD, Quanterix Corp is Undervalued by 40%.